We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Comply with good manufacturing practice (GMP) and good distribution practice (GDP), and prepare for an inspection.
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
How to apply for an authorisation to manufacture authorised veterinary medicines or medicines marketed under the Exemptions for small pet animals.
How to show MHRA you're meeting good clinical practice (GCP) standards and what to expect from an inspection.
The UK Good Laboratory Practice Monitoring Authority (UK GLPMA) recognises that there are potential challenges COVID-19 will present to members of the GLP monitoring programme.
These published standards relate to a number of KPIs in the VMD Deliverables and KPI document.
Qualified Persons (QPs) should follow the below guidance on the flexible approaches we are taking for medicines imported from third countries.
Keep up to date with the latest information from the UK GLP monitoring authority.
Registers of authorised manufacturers, wholesale dealer sites and retailers.
Guidance for industry on flexible approaches to regulation we are taking during the COVID-19 outbreak.
Register as a manufacturer, importer or distributor of active substances for use in veterinary medicines.
The MHRA is part of the Access Consortium along with the Therapeutic Goods Administration, Health Canada, Health Sciences Authority of Singapore and Swissmedic.
Apply for an authorisation to manufacture extemporaneous preparations, autogenous vaccines, stem cell products or blood products for non-food animals.
Guidance for GLP facilities on implementing and maintaining a risk-based quality assurance programme.
Access Consortium Statement on Good Manufacturing Practice (GMP) Inspections Reliance and Recognition
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).